Cognizant
CTSH · What the business does, what can go wrong, and how options sellers approach it
What it does
Cognizant is a global IT services and consulting company. It helps large organizations build, run and modernize their technology systems. Its clients are mostly big enterprises in industries such as financial services, healthcare, and manufacturing and other resource-related sectors.
Services include software development, cloud migration, data and analytics work, digital product engineering, and business process outsourcing. A large share of its workforce is based in India, and it uses a global delivery model that blends onshore and offshore teams.
How it makes money
Cognizant earns fees for the work its people do. Contracts are usually either time-and-materials (billed by effort) or fixed-price projects. Many are multi-year managed services agreements that run part of a client's technology operations.
Profit depends on keeping consultants busy (utilization), pricing work well, and managing labor costs, including wages, hiring and attrition.
Why investors own it
- Large enterprises tend to keep spending on technology, and outsourcing can lower their costs.
- Multi-year contracts can give some revenue visibility.
- The business does not require heavy capital spending, so it can generate steady cash flow.
- Some investors like that the company returns cash through share repurchases and dividends, though these are decisions the board can change.
What can go wrong
- Clients cut or delay technology budgets when the economy weakens.
- Competition from other IT services firms can pressure pricing.
- Automation and generative AI could reduce the hours clients need to buy, and could shift how work is priced.
- Wage inflation, high attrition and visa or immigration rules can raise costs.
- Currency swings, especially involving the Indian rupee, can affect margins.
- Heavy exposure to financial services and healthcare ties results to those sectors.
What to watch
- Revenue growth in constant currency
- New contract bookings and the size of the backlog
- Operating margin
- Employee attrition and headcount trends
- Client spending commentary in financial services and healthcare
- Management's full-year guidance updates
- Progress on AI-related services
Options income angle
Options on CTSH are generally available across several expirations, but liquidity is usually thinner than for the largest mega-cap names. Bid-ask spreads can be wider, especially on strikes far from the current price.
Implied volatility tends to rise ahead of quarterly earnings and guidance updates, and with shifts in views on IT spending and AI disruption. A caution for premium sellers: a sharp earnings-day move can quickly overwhelm the premium collected, so know how a position would be handled if the stock gaps through a strike.
What the latest 10-K says
A plain-English read of the Risk Factors and Management's Discussion in the 10-K for the year ended December 31, 2025, filed February 12, 2026. Figures are as the filing reports them. Read the filing on SEC.gov
The filing in brief
Cognizant grew revenue in 2025 and widened its operating margin, helped by its NextGen cost program and the Belcan acquisition. A one-time tax charge of $390 million held net income roughly flat. The filing also stresses that AI is both a major investment area and a threat to some services the company has historically sold.
How the business did
- Revenues were $21,108 million, up $1,372 million or 7.0%. The Belcan acquisition contributed 260 basis points of that growth (a basis point is one hundredth of a percentage point).
- Operating margin rose to 16.1% from 14.7%, on NextGen savings, operational efficiencies and a weaker Indian rupee, partly offset by higher compensation costs. Income from operations included a $62 million gain on the sale of an office complex in India.
- Net income was $2,230 million versus $2,240 million, and diluted EPS was $4.56 versus $4.51. The cause was a one-time, non-cash tax expense of $390 million after a U.S. tax law change, which cut EPS by $0.80. Adjusted Diluted EPS, which strips out unusual items, was $5.28 versus $4.75.
- Health Sciences and Financial Services grew on the ramp-up of several large deals. Products and Resources rose 10.5%, largely from Belcan. CMT rose only 1.0%, with weakness among communications and media customers.
- Net cash from operating activities was $2,883 million versus $2,124 million, and free cash flow was $2,665 million versus $1,827 million. Financing outflows rose to $2,272 million, mainly from higher share repurchases.
Risks specific to this company
- India dependence: A significant majority of operations and technical staff are in India. Wage inflation and rupee swings there can raise costs, and each 1.0% move in the rupee shifts operating margin by approximately 17 basis points before hedges.
- Visas and offshoring politics: A substantial portion of employees in the U.S. and Europe rely on work visas, and the U.S. operating subsidiary uses many H-1B and L-1 holders. Tighter immigration rules or anti-outsourcing legislation could hurt staffing and the offshore delivery model.
- AI disruption: Some services historically performed for clients have been and will continue to be replaced by AI or automation. Clients may also build their own AI capabilities or in-house centers, or resist new pricing models.
- Short-term contracts and client mix: Many contracts can be ended on short notice, and revenues depend heavily on clients in the United States and Europe, especially in financial services and healthcare.
- Indian tax dispute: The Indian tax authority claims additional taxes are owed on two share repurchases by the company's India subsidiary. A $360 million payment was made in January 2024 in connection with this dispute.
- Indian labor reform: New labor codes led to a one-time $147 million increase in a pension-type liability, and further rules could raise costs in 2026 and later.
What management is watching
- Client demand for AI-ready, data-enabled transformation work, alongside demand for productivity and cost savings. Management also points to tariffs, regulation and global economic uncertainty as pressures on discretionary spending.
- Continued significant investment in AI capabilities.
- Capital allocation: roughly 50% of free cash flow for acquisitions and 50% for share repurchases and dividends. Amounts in any period may vary.
- Talent measures: Voluntary Attrition - Tech Services was 13.9% versus 15.9%, and the company ended 2025 with approximately 351,600 employees.
- Liquidity and tax items: The $650 million Term Loan and $1,850 million revolving credit facility mature in October 2027, with no revolver balance outstanding at year end. Management also flags a possible higher effective tax rate from the India-Mauritius treaty amendment.
What the latest 10-Q says
A plain-English read of Management's Discussion (and any new or changed risk factors) in the 10-Q for the quarter ended September 30, 2026, filed October 29, 2026. Figures are as the filing reports them. Read the filing on SEC.gov
The quarter in brief
Cognizant reported revenue of $5,664 million for the quarter ended September 30, 2026, up 4.6% from a year earlier. Adjusted operating margin rose to 16.3% from 16.0%, while the reported (GAAP) operating margin fell to 15.4% from 16.0% because of $51 million in Project Leap restructuring costs. The company also revised its estimate of total Project Leap costs to $180 million to $250 million.
How the business did
- Revenue: Growth was 4.6%, or 4.8% in constant currency (which strips out exchange-rate effects). Nine-month revenue was $16,558 million, up 5.0%. Financial Services rose 12.0% and CMT rose 10.5%, while Health Sciences fell 1.1% and Products and Resources fell 0.9%. Acquisitions added about 210 basis points to growth and third-party product sales added 190 basis points (a basis point is one hundredth of a percentage point).
- Profit: Income from operations was $872 million versus $866 million. Diluted EPS was $1.39 versus $0.56, but the prior-year quarter included a one-time, non-cash tax expense of $390 million. Adjusted diluted EPS was $1.49 versus $1.39. Project Leap savings and a weaker Indian rupee helped margin, while higher compensation costs and acquisitions weighed on it.
- Cash flow: Nine-month operating cash flow was $1,836 million versus $2,025 million, mainly because of higher incentive pay. Days sales outstanding, the average time to collect from clients, was 89 days versus 81 days at December 31, 2025.
- Capital return and debt: The company repurchased $1,838 million of its Class A common stock in 2026, including $500 million through ASR agreements (accelerated share repurchases). It had $1,000 million outstanding on its revolving credit facility and $1,552 million of cash, cash equivalents and short-term investments.
What management is watching
- Project Leap: Management expects $140 million to $160 million of costs in 2026, with the rest through the first quarter of 2027. It expects in-year savings of approximately $200 million in 2026, used mainly to fund investments in AI and integrated offerings.
- Client demand and AI: Clients may increasingly demand productivity and cost savings. The company plans significant AI investments and says AI could reduce demand and pricing for some services it provides to clients.
- India: Labor law clarifications could affect compensation and benefit expenses. An amended India-Mauritius tax treaty, in force since August 2026, could increase the effective income tax rate.
- Financing and measures: On October 5, 2026, the company entered a new credit agreement with a $550 million term loan and a $1,850 million revolving facility, both due in October 2031. It points investors to Adjusted Operating Margin, Adjusted Diluted EPS and constant currency growth.
New or changed risks
- Disruption from Project Leap: The filing adds a risk factor saying headcount reductions may disrupt operations, cause loss of institutional knowledge and make it harder to recruit and retain employees, which could hurt client delivery.
- Costs and savings may miss plan: Project Leap may not deliver the expected savings, and actual costs or cash payments could exceed the $180 million to $250 million estimate or include charges not yet contemplated.
Follow CTSH in Kortex
The Kortex app shows CTSH's price, options chain and IV rank, and answers your questions from live market data and SEC filings.
Free to download.
Learn the strategies
More stock briefs
For education only, not financial advice. Options involve risk and are not suitable for every investor.